论文部分内容阅读
目的:探讨影响异位妊娠MTX保守治疗的相关因素。方法:回顾分析113例异位妊娠MTX保守治疗病例。结果:治疗总成功率91.2%,用药前血β-HCG<2 000 IU/L与血β-HCG≥2000IU/L两组成功率比较差异有统计学意义(P<0.05),孕龄及异位妊娠包块大小与成功率无明显关系(P>0.05),而异位妊娠相关临床症状与成功率有明显相关性(P<0.05),在成功患者中有76.1%的病例血β-HCG呈稳降型曲线变化。结论:血β-HCG并非是影响疗效的独立危险因素,综合客观分析异位妊娠相关因素适时干预治疗是保守治疗成功的关键。
Objective: To explore the factors that influence the conservative treatment of MTX in ectopic pregnancy. Methods: A retrospective analysis of 113 cases of ectopic pregnancy MTX conservative treatment. Results: The success rate of treatment group was 91.2%. There was significant difference in the success rates of β-HCG <2000 IU / L and blood β-HCG≥2000 IU / L before treatment (P <0.05), gestational age and ectopic There was no significant relationship between the size of pregnancy mass and the success rate (P> 0.05), while the clinical symptoms and success rate of ectopic pregnancy were significantly correlated (P <0.05). Among the successful patients, 76.1% Steady drop curve changes. Conclusion: Blood β-HCG is not an independent risk factor affecting the curative effect. Comprehensive and objective analysis of ectopic pregnancy-related factors timely intervention is the key to the success of conservative treatment.